Glaxo Gives Up One Of Three Patents For Avandia In China
U.K. drug maker GlaxoSmithKline has abandoned its claim to a Chinese patent for a component of its popular diabetes drug Avandia, but is holding on to two other patents on the...To view the full article, register now.
Already a subscriber? Click here to view full article